Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cross

Showing results (341-350 of 595) with videos related to

Pageof 60
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2007
The effect of epithelial and stromal tumor components on FIGO stages III and IV ovarian carcinosarcomas treated with primary surgery and chemotherapyR Athavale, N Thomakos, K Godfrey, et al.
Leukemia|March 25, 2005
Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6/ABL1 fusion transcriptS Meyer-Monard, D Mühlematter, A Streit, et al.
Haematologica|January 13, 2010
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αSebastian Kreil, Katherine Waghorn, Thomas Ernst, et al.
Blood|April 26, 2007
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaSebastian Kreil, Markus Pfirrmann, Claudia Haferlach, et al.
Leukemia Research|July 24, 2010
JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapyRichard T Silver, Katherine Vandris, Y Lynn Wang, et al.
Haematologica|October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individualsAndrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Leukemia|July 8, 2020
Is cancer latency an outdated concept? Lessons from chronic myeloid leukemiaManuel Abecasis, Nicholas C P Cross, Manuel Brito, et al.
Haematologica|November 5, 2013
JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drugEmil T Kuriakose, Stefani Gjoni, Y Lynn Wang, et al.
Acta Haematologica|November 23, 2007
Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individualsY Lynn Wang, Joong W Lee, Jonathan S Kui, et al.
Genes, Chromosomes & Cancer|November 14, 2008
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2)Christoph Walz, Claudia Haferlach, Annette Hänel, et al.
Pageof 60

Showing results (341-350 of 595) with videos related to

Sort By:
Pageof 60
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 1, 2007
The effect of epithelial and stromal tumor components on FIGO stages III and IV ovarian carcinosarcomas treated with primary surgery and chemotherapyR Athavale, N Thomakos, K Godfrey, et al.
Leukemia|March 25, 2005
Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6/ABL1 fusion transcriptS Meyer-Monard, D Mühlematter, A Streit, et al.
Haematologica|January 13, 2010
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αSebastian Kreil, Katherine Waghorn, Thomas Ernst, et al.
Blood|April 26, 2007
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaSebastian Kreil, Markus Pfirrmann, Claudia Haferlach, et al.
Leukemia Research|July 24, 2010
JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapyRichard T Silver, Katherine Vandris, Y Lynn Wang, et al.
Haematologica|October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individualsAndrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Leukemia|July 8, 2020
Is cancer latency an outdated concept? Lessons from chronic myeloid leukemiaManuel Abecasis, Nicholas C P Cross, Manuel Brito, et al.
Haematologica|November 5, 2013
JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drugEmil T Kuriakose, Stefani Gjoni, Y Lynn Wang, et al.
Acta Haematologica|November 23, 2007
Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individualsY Lynn Wang, Joong W Lee, Jonathan S Kui, et al.
Genes, Chromosomes & Cancer|November 14, 2008
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2)Christoph Walz, Claudia Haferlach, Annette Hänel, et al.
Pageof 60